Inhibition of human recombinant HDAC1 pre-incubated for 30 mins before Ac-Leu- Gly-Lys(Ac)-AMC substrate addition and measured after 90 mins by fluorescence based assay
Inhibition of human recombinant HDAC2 pre-incubated for 30 mins before Ac-Leu- Gly-Lys(Ac)-AMC substrate addition and measured after 90 mins by fluorescence based assay
Inhibition of human recombinant HDAC3 pre-incubated for 30 mins before Ac-Leu- Gly-Lys(Ac)-AMC substrate addition and measured after 90 mins by fluorescence based assay
Inhibition of human recombinant HDAC8 pre-incubated for 30 mins before Ac-Leu- Gly-Lys(Ac)-AMC substrate addition and measured after 90 mins by fluorescence based assay
Inhibition of human recombinant HDAC7 pre-incubated for 15 mins before Ac-Leu-Gly-Lys(trifluroAc)-AMC substrate addition and measured after 60 mins by fluorescence based assay
Potency index, ratio of IC50 for AR-42 to IC50 for test compound for inhibition of human recombinant HDAC1 pre-incubated for 30 mins before Ac-Leu- Gly-Lys(Ac)-AMC substrate addition and measured after 90 mins by fluorescence based assay
Potency index, ratio of IC50 for AR-42 to IC50 for test compound for cytotoxicity against human A549 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
Potency index, ratio of IC50 for AR-42 to IC50 for test compound for cytotoxicity against human HT-29 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
Potency index, ratio of IC50 for AR-42 to IC50 for test compound for cytotoxicity against human HeLa cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
Potency index, ratio of IC50 for AR-42 to IC50 for test compound for cytotoxicity against human MDA-MB-231 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
Potency index, ratio of IC50 for AR-42 to IC50 for test compound for cytotoxicity against human MM96L cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay
Selectivity index, ratio of IC50 for cytotoxicity against human neonatal foreskin fibroblasts by MTT assay to IC50 for cytotoxicity against human A549 cells by MTT assay
Selectivity index, ratio of IC50 for cytotoxicity against human neonatal foreskin fibroblasts by MTT assay to IC50 for cytotoxicity against human HT-29 cells by MTT assay
Selectivity index, ratio of IC50 for cytotoxicity against human neonatal foreskin fibroblasts by MTT assay to IC50 for cytotoxicity against human HeLa cells by MTT assay
Selectivity index, ratio of IC50 for cytotoxicity against human neonatal foreskin fibroblasts by MTT assay to IC50 for cytotoxicity against human MDA-MB-231 cells by MTT assay
Selectivity index, ratio of IC50 for cytotoxicity against human neonatal foreskin fibroblasts by MTT assay to IC50 for cytotoxicity against human MM96L cells by MTT assay